BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18818885)

  • 1. Eosinophils and their interactions with respiratory virus pathogens.
    Rosenberg HF; Dyer KD; Domachowske JB
    Immunol Res; 2009; 43(1-3):128-37. PubMed ID: 18818885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice.
    Percopo CM; Qiu Z; Phipps S; Foster PS; Domachowske JB; Rosenberg HF
    J Immunol; 2009 Jul; 183(1):604-12. PubMed ID: 19542471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated mouse eosinophils protect against lethal respiratory virus infection.
    Percopo CM; Dyer KD; Ochkur SI; Luo JL; Fischer ER; Lee JJ; Lee NA; Domachowske JB; Rosenberg HF
    Blood; 2014 Jan; 123(5):743-52. PubMed ID: 24297871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation.
    Cortjens B; Lutter R; Boon L; Bem RA; van Woensel JB
    PLoS One; 2016; 11(12):e0168779. PubMed ID: 28005954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Airway Hyperresponsiveness Following Recovery from Infection with Pneumonia Virus of Mice.
    Limkar AR; Percopo CM; Redes JL; Druey KM; Rosenberg HF
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33922096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique nonstructural proteins of Pneumonia Virus of Mice (PVM) promote degradation of interferon (IFN) pathway components and IFN-stimulated gene proteins.
    Dhar J; Barik S
    Sci Rep; 2016 Dec; 6():38139. PubMed ID: 27905537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens.
    Rosenberg HF; Domachowske JB
    J Leukoc Biol; 2001 Nov; 70(5):691-8. PubMed ID: 11698487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice.
    Domachowske JB; Bonville CA; Dyer KD; Easton AJ; Rosenberg HF
    Cell Immunol; 2000 Mar; 200(2):98-104. PubMed ID: 10753501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.
    Garcia-Crespo KE; Chan CC; Gabryszewski SJ; Percopo CM; Rigaux P; Dyer KD; Domachowske JB; Rosenberg HF
    Antiviral Res; 2013 Mar; 97(3):270-9. PubMed ID: 23274789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
    Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
    mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid administration accelerates mortality of pneumovirus-infected mice.
    Domachowske JB; Bonville CA; Ali-Ahmad D; Dyer KD; Easton AJ; Rosenberg HF
    J Infect Dis; 2001 Dec; 184(12):1518-23. PubMed ID: 11740726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.
    Dyer KD; Percopo CM; Fischer ER; Gabryszewski SJ; Rosenberg HF
    Blood; 2009 Sep; 114(13):2649-56. PubMed ID: 19652202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.
    Castilow EM; Meyerholz DK; Varga SM
    J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization strategies for the prevention of pneumovirus infections.
    Bennett N; Ellis J; Bonville C; Rosenberg H; Domachowske J
    Expert Rev Vaccines; 2007 Apr; 6(2):169-82. PubMed ID: 17408367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pneumonia virus of mice as a possible human pathogen.
    Brock LG; Karron RA; Krempl CD; Collins PL; Buchholz UJ
    J Virol; 2012 May; 86(10):5829-43. PubMed ID: 22438539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.
    van Helden MJ; van Kooten PJ; Bekker CP; Gröne A; Topham DJ; Easton AJ; Boog CJ; Busch DH; Zaiss DM; Sijts AJ
    Vaccine; 2012 Oct; 30(45):6382-8. PubMed ID: 22940382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice.
    Barends M; de Rond LG; Dormans J; van Oosten M; Boelen A; Neijens HJ; Osterhaus AD; Kimman TG
    Clin Exp Allergy; 2004 Mar; 34(3):488-96. PubMed ID: 15005745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.
    Dyer KD; Garcia-Crespo KE; Glineur S; Domachowske JB; Rosenberg HF
    Viruses; 2012 Dec; 4(12):3494-510. PubMed ID: 23342367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory viruses and eosinophils: exploring the connections.
    Rosenberg HF; Dyer KD; Domachowske JB
    Antiviral Res; 2009 Jul; 83(1):1-9. PubMed ID: 19375458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 28 days later: eosinophils stop viruses.
    Lacy P
    Blood; 2014 Jan; 123(5):609-11. PubMed ID: 24482499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.